Jilin University , China
Title Of Presentation :
Activin A regulates proliferation and migration of human breast cancer cells
Xueling Cui has her expertise in tumor immunity and innate immune cell migration. Her study on the tumor biotherapy based on activin signaling transduction reveals new gene targets for tumor therapy. Relevant research work has been carried out successively in laboratories in Japan and Canada. So far, about 20 papers have been published in Experiment Cell Research、Open Biology、Cellular Molecular Immunology, Scientist Report and other academic journals.